The 5 analysts offering 12-month price forecasts for Chromadex Corp have a median target of 16.00, with a high estimate of 17.00 and a low estimate of 12.00. The median estimate represents a +226.53% increase from the last price of 4.90.
The current consensus among 5 polled investment analysts is to Buy stock in Chromadex Corp. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.10
Reporting Date Mar 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.